Nucleai is a company that develops an AI-powered spatial biology platform for drug development and clinical treatment. It allows pharmaceutical companies, contract research organizations, and diagnostics laboratories to improve clinical trials and clinical decision-making. The company uses tissue datasets to produce insights into cancer biology.